Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR3223)
Drug Name
PF-06463922
Synonyms SCHEMBL15274056
Indication Lung cancer [ICD11: 2C25] Phase 2 [1]
Solid tumour/cancer [ICD11: ICD11: 2A00-2F9Z] Phase 1/2 [2]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 406.4 Topological Polar Surface Area 110
Heavy Atom Count 30 Rotatable Bond Count 0
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 7
Cross-matching ID
PubChem CID
71731823
ChEBI ID
CHEBI:143117
CAS Number
1454846-35-5
TTD Drug ID
D04DYC
Formula
C21H19FN6O2
Canonical SMILES
C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C
InChI
InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1
InChIKey
IIXWYSCJSQVBQM-LLVKDONJSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Lorlatinib benzoic acid metabolite (M8) DM006433
89816280
Unclear - Unclear 1 [3]
PF-06463922 Metabolite M15 DM019251 N. A. Unclear - Unclear 1 [3]
PF-06463922 Metabolite M1a DM019252 N. A. Unclear - Unclear 1 [3]
PF-06463922 Metabolite M2a DM016397
89807965
Unclear - Unclear 1 [3]
PF-06463922 Metabolite M4a DM019250 N. A. Unclear - Unclear 1 [3]
PF-06463922 Metabolite M5 DM019249 N. A. Unclear - Unclear 1 [3]
PF-06463922 Metabolite M6 DM019247 N. A. Unclear - Unclear 1 [3]
PF-06898840 DM019243 N. A. Unclear - Unclear 1 [3]
PF-06463922 Metabolite M14 DM019248 N. A. Unclear - Unclear 2 [3]
PF-06463922 Metabolite M16 DM019244 N. A. Unclear - Unclear 2 [3]
PF-06463922 Metabolite M17 DM019245 N. A. Unclear - Unclear 2 [3]
PF-06463922 Metabolite M3a DM019246 N. A. Unclear - Unclear 2 [3]
PF-06463922 Metabolite M4a DM019250 N. A. Unclear - Unclear 2 [3]
PF-06811569 DM016580
130409597
Unclear - Unclear 2 [3]
⏷ Show the Full List of 14  DM(s)
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR011750 PF-06463922 PF-06895751 (M8) Unclear - Unclear UGT1A4 ... [3]
MR011752 PF-06463922 PF-06898840 Unclear - Unclear Unclear [3]
MR011755 PF-06463922 PF-06463922 Metabolite M2a Unclear - Unclear Unclear [3]
MR011757 PF-06463922 PF-06463922 Metabolite M6 Unclear - Unclear Unclear [3]
MR011759 PF-06463922 PF-06463922 Metabolite M5 Unclear - Unclear Unclear [3]
MR011761 PF-06463922 PF-06463922 Metabolite M4a Unclear - Unclear Unclear [3]
MR011762 PF-06463922 PF-06463922 Metabolite M15 Unclear - Unclear Unclear [3]
MR011763 PF-06463922 PF-06463922 Metabolite M1a Unclear - Unclear Unclear [3]
MR011756 PF-06463922 Metabolite M2a PF-06463922 Metabolite M3a Unclear - Unclear Unclear [3]
MR011760 PF-06463922 Metabolite M5 PF-06463922 Metabolite M4a Unclear - Unclear Unclear [3]
MR011758 PF-06463922 Metabolite M6 PF-06463922 Metabolite M14 Unclear - Unclear Unclear [3]
MR011751 PF-06895751 (M8) PF-06811569 Unclear - Unclear Unclear [3]
MR011753 PF-06898840 PF-06463922 Metabolite M16 Unclear - Unclear Unclear [3]
MR011754 PF-06898840 PF-06463922 Metabolite M17 Unclear - Unclear Unclear [3]
⏷ Show the Full List of 14 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 2C8 (CYP2C8) DME0018 Homo sapiens
CP2C8_HUMAN
1.14.14.1
[3]
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[3]
Cytochrome P450 3A5 (CYP3A5) DME0012 Homo sapiens
CP3A5_HUMAN
1.14.14.1
[3]
Mephenytoin 4-hydroxylase (CYP2C19) DME0021 Homo sapiens
CP2CJ_HUMAN
1.14.14.1
[3]
UDP-glucuronosyltransferase 1A3 (UGT1A3) DME0041 Homo sapiens
UD13_HUMAN
2.4.1.17
[3]
UDP-glucuronosyltransferase 1A4 (UGT1A4) DME0048 Homo sapiens
UD14_HUMAN
2.4.1.17
[3]
⏷ Show the Full List of 6  DME(s)
References
1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7476).
3 The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.